GL1X · GenesisL1 explorer

MolNFT v1 · #165706 · protein

PCSK9 in complex with compound 2

6U3X · Proprotein convertase SUBTILISIN/KEXIN type 9: “PCSK9 in complex with compound 2”. X-ray diffraction, 1 ligand (PVV), 5 pockets (best druggability 0.75). MolNFT v1 #165706 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6U3X
Type
protein
Length
578 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proprotein convertase SUBTILISIN/KEXIN type 9
EC
3.4.21.-
UniProt
Q8NBP7
Ligands
PVV
Pockets
5 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 19% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein9230% helix, 39% strandQ8NBP7
BProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein48617% helix, 37% strandQ8NBP7

Ligands and binding sites

  • PVV · 2-[(1R)-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]-N-(1,3-thiazol-2-yl) acetamide · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16990.750.8087PVV
22990.700.8441empty
31690.460.7531empty
41160.410.7634empty
5580.290.7413empty

Interfaces

1 interface between chains.

  • A–B · 1390 Ų buried · 25 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide (disulfide).

Compared structures

  • 6U3X · PCSK9 in complex with compound 2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.